Enduring Activity

Live Tumor Board! Experts Navigate the Impact of Neutropenia Across Tumor Types

Oncology Briefings&trade;

Oncology Briefings™: Analyzing the Evidence of Biosimilars in HER2-Positive and Supportive Breast Cancer Care Settings

Expert Illustrations & Commentaries

Medical Crossfire®: Practical Considerations for Integrations of Biosimilars Into Patient Care Pathways for Hematologic Malignancies

This activity will review available BCMA therapies, as well as guideline recommendations for incorporating these agents into therapy.

Emerging BCMA-Targeted Therapies for Relapsed or Refractory Multiple Myeloma

This activity will review the role of the pharmacist in the care of patients with metastatic CRC, illustrating how pharmacists can be involved in clinical decisions, therapy management, and transitions of care.

Advances in Treatment Options Using Biomarkers in Metastatic Colorectal Cancer: An Update for Pharmacists

This article will review recent and ongoing advancements and present the newest clinical data surrounding multi-cancer detection for managed care professionals to become familiar with and potentially incorporate these preventive screening into treatment paradigms for patients.

Examining Developments in Multi-Cancer Early Detection: Highlights of New Clinical Data from Recent Conferences

Examining Developments in Multicancer Early Detection: Highlights of New Clinical Data from Recent Conferences

This activity will review the place in therapy for biomarker-directed treatments, as well as the clinical data supporting their use in NSCLC.  

Frontline Therapies for Non-Small Cell Lung Cancer: Optimizing Outcomes With Immune Checkpoint Inhibitors

This activity will outline current and emerging antifungals for treatment of VVC and equip pharmacists with knowledge of how to properly assess, recommend, and manage VVC drug therapy to treat bothersome infections, as well as limit recurrent infections and optimize care of their patients. 

A Review of Novel Antifungal Therapies for Vulvovaginal Candidiasis to Improve Patient Outcomes and Prevent Recurrent Infections

This activity will examine the important role of pharmacists and managed care professionals when assessing therapies and potential sequencing options for patients with bladder cancer to achieve optimal outcomes.

Assessing Effective Treatment Options for Bladder Cancer: Examining Current and Emerging Therapies

This activity will review the use of DOACs for extended duration prophylaxis of VTEs and prevention of complications patients at high risk of VTE may face post discharge.  

Venous Thromboembolism Prevention: How to Identify and Manage Patients at Risk

Pharmacists can have significant roles in promoting screening for PAH in patients with CTDs to initiate early, effective treatment. 

The Pharmacist’s Role in the Management of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: Strategies to Address Challenges and Improve Patient Care

Managed care professionals must prepare to review treatment options, incorporate them into formularies, and develop cost-efficient administration plans to improve adherence, optimize patient outcomes, and limit adverse effects.

Addressing the Unmet Needs of Patients With Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema With Novel and Emerging Monoclonal Antibody

This activity will prepare pharmacists to effectively manage anemia in this heterogenous patient population with a focus on strategies utilizing intravenous iron.

Iron Deficiency Anemia in Patients With Cancer and the Pharmacist’s Role

This article will detail the impact and effects of cigarette smoking and equip pharmacy technicians with knowledge about nicotine replacement therapies and strategies to encourage smoking cessation among patients.

Conversational Approaches for Pharmacy Technicians to Assist With Smoking Cessation Efforts

This activity will provide pharmacists with an in-depth review of connective tissue disease-associated pulmonary arterial hypertension management and treatment guidelines including recent data to best manage patients’ treatment expectations. 

The Role of the Pharmacist in Addressing the Challenges of Treating Pulmonary Arterial Hypertension Associated With Connective Tissue Diseases

This activity will explore strategies for oncology practitioners to employ a multidisciplinary approach to facilitate incorporation of PARP inhibitors in their patient care.

Exploring Strategies for Treating Solid Tumors With PARP Inhibitors (Pharmacist Credit)

This activity will review dosing and administration specifications for intravenous (IV) and subcutaneous (SC) Ig therapies in the management of PIDD, and, specifically, transitioning from IV to SC Ig therapies. 

Updates for the Pharmacist on Intravenous and Subcutaneous Immunoglobulins in Primary Immunodeficiency Disease, featuring Patient Case Reviews

This activity will address evidence supporting use of immunotherapeutic and targeted therapies in patients with bladder cancer to assist members of the oncology care team in making proactive treatment decisions and individualized management plans in accordance with guideline recommendations. 

Locally Advanced and Metastatic Bladder Cancer: Transforming the Treatment Paradigm (Technician Credit)

Exploring Strategies for Treating Solid Tumors With PARP Inhibitors (Technician Credit)

This program will prepare physicians, nurses, and pharmacists involved in the care of patients with CLL to recommend appropriate therapies for patients and navigate the changing landscape of CLL treatment.

Exploring the Advancements of Evidence-Based Testing and Treatment Strategies in CLL (Technician Credit)

This activity will discuss considerations for effective patient counseling and management throughout the continuum of treatment for patients with adjuvant and metastatic melanoma.  

Evolving Treatment Strategies for Adjuvant and Metastatic Melanoma: A Multidisciplinary Approach to Care (Technician Credit)

This activity will address barriers to adoption of biosimilars members of the oncology care team may encounter in their practice and present strategies to promote the safe use of biosimilars in clinical practice.  

Oncology Biosimilars: Educating the Oncology Health Care Team to Facilitate Implementation Into Clinical Practice (Pharmacist Credit)

This activity will address the appropriate place in therapy for oral oncolytic agents and how physicians, nurses, and pharmacists can guide treatment decisions and assist in developing patient-specific management plans to optimize care for patients on these therapies.

New and Emerging Oral Oncolytics and the Role of the Oncology Team in Optimizing Patient Outcomes (Technician Credit)

New and Emerging Oral Oncolytics and the Role of the Oncology Team in Optimizing Patient Outcomes (Pharmacist Credit)

Oncology Biosimilars: Educating the Oncology Health Care Team to Facilitate Implementation Into Clinical Practice (Technician Credit)

Evolving Treatment Strategies for Adjuvant and Metastatic Melanoma: A Multidisciplinary Approach to Care (Pharmacist Credit)

Exploring the Advancements of Evidence-Based Testing and Treatment Strategies in CLL (Pharmacist Credit)

Locally Advanced and Metastatic Bladder Cancer: Transforming the Treatment Paradigm (Pharmacist Credit)

This activity will educate pharmacists on different biosimilar efficacy in IBD, their monitoring parameters, and how to manage potential adverse effects. 

Proper Use and the Role of Biosimilars in Inflammatory Bowel Disease Treatment to Improve Outcomes and Access to Care: Key Considerations for Pharmacists

This article will discuss common oral health conditions as well as tips pharmacy technicians can share with patients to prevent progression of oral disease.

Sink Your Teeth Into Common Oral Health Conditions: A Review for Pharmacy Technicians

This activity will present efficacy and safety data for high-dose IV iron therapies, as well as the role of early initiation of IV iron in certain clinical situations and important considerations for protocols. 

Management of Iron Deficiency Anemia: Understanding Disease Burden, Use of High-Dose IV Iron Replacement Therapies, and the Role of the Pharmacist in Treatment on Demand

Management of Iron Deficiency Anemia: Understanding Disease Burden, Use of High-Dose IV Iron Replacement Therapies, and the Role of the Pharmacist in Treatment 

This activity will explore potential polypharmacy concerns and drug–drug interactions of therapies for insomnia to assist pharmacists in identifying appropriate therapies for older adult patients with insomnia. 

Managing Insomnia in Older Patients: Facilitating Individualized Treatment to Close Gaps in Care

1.5 Credit(s) / Endocrinology, Nephrology

The expert panelists will discuss the current landscape of CKD prevention and management including renal protective strategies and emerging treatments.

Slowing the Progression of Chronic Kidney Disease in Patients With Diabetes: Managed Care Interventions to Address Treatment Gaps

This activity will focus on approved CAR T-cell therapies as well as guideline recommendations for place in the treatment paradigm.

The Broadening Utility of CAR T-Cell Therapy: Challenges and Opportunities to Expand Access

This activity will detail the importance of providing patient-centered care and review opportunities for pharmacists to assist with appropriate pharmacologic management of patients with migraine. 

The Role of CGRP-Targeted Therapies in the Management of Migraine: Examining Opportunities for Pharmacist Intervention

This activity will explore the clinical data and guideline recommendations for the treatment of TNBC as well as strategies for formulary management.

Triple-Negative Breast Cancer: Perspectives on the Disparities in Care and Managed Care Considerations for the Advancing Treatment Paradigm

To provide access to cost-effective treatment for patients, managed care professionals need to be familiar with the clinical data and indications for use of these agents in HER2-positive disease.

Metastatic HER2-Positive Breast Cancer: Innovative Therapeutic Options and Updates for Managed Care

This activity will feature patient case discussions and address challenges contributing to selection of therapy, management of adverse effects, and coordination of care for patients with RCC.

Updates in the Frontline Treatment of Renal Cell Carcinoma: Guiding Pharmacists in Effective Management of Combination Therapies, featuring Patient Case Discussions

This program will review available oncology biosimilars, potential benefits and challenges in use, and will also emphasize payer strategies to help assist with access to care and prescriber acceptance into clinical practice.

Evaluating the Utilization of Biosimilars in Oncology: Managed Care Considerations

This discussion will center on clinical data for agents under investigation for treatment of MS as well as managed care considerations for facilitating access to medications as they become available.

Multiple Sclerosis: Managed Care Approaches to Navigating the Treatment Landscape

This activity will review the benefits and challenges associated with emerging DME and nAMD therapies.

Exploring Emerging Monoclonal Antibody Therapy for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Pharmacists and managed care professionals can have significant impact in providing quality care by facilitating access to treatment and helping overcome treatment challenges.

Insights into Sickle Cell Disease: Complexities of Care

This activity will review the clinical data for incorporating monoclonal antibodies into the treatment paradigm of multiple myeloma.

Multiple Myeloma: Optimizing Outcomes for Patients on Monoclonal Antibody Therapy

This webinar will report upon recent clinical trial research in atopic dermatitis and upcoming treatment options.

Novel and Developing JAK Inhibitors for Atopic Dermatitis: Updates on Clinical Trial Data and Their Place in Therapy 

December 14th, 2021 | 6:00 pm & 8:00 pm ET

Managed Care Considerations: Targeting the Janus Kinase Pathway in Atopic Dermatitis and Alopecia Areata

PTCE will host 10 Virtual Symposia conducted at the 2021 ASHP Midyear Clinical Meeting and Exhibition.

PTCE Sessions at ASHP Midyear 2021

Specialty pharmacists in particular must be able to interpret nuances in changing from IVIg to SCIg formulations for patients with CIPD as well as be aware of the monitoring and optimization of CIDP therapy.

Clinical Updates in the Management of CIDP: What Pharmacists Need to Know

Proper education and routine follow-up can improve patient adherence and outcomes. This activity includes a patient perspective interview that will provide pharmacists with further insight into the diagnosis, treatment experience, and challenges of a patient with ITP.

Continuing Education